Literature DB >> 26433140

Impact of Reduced Glomerular Filtration Rate and Proteinuria on Overall Survival of Patients with Renal Cancer.

Mouafak Tourojman1, Samer Kirmiz2, Bradley Boelkins2, Sabrina L Noyes1, Alan T Davis3, Kelly O'Donnell2, Conrad M Tobert2, Brian R Lane4.   

Abstract

PURPOSE: Although it is commonly staged according to glomerular filtration rate, an international work group recommended classifying chronic kidney disease by cause, glomerular filtration rate and albuminuria. Data on nonsurgical patients with chronic kidney disease indicate proteinuria to be an independent predictor of renal function decrease and mortality. We evaluated whether preoperative proteinuria impacted survival in patients undergoing nephrectomy.
MATERIALS AND METHODS: An institutional registry was queried for information regarding preoperative creatinine/glomerular filtration rate and urinalysis in 900 patients, including 362 and 538 treated with partial and radical nephrectomy, respectively. Patients were grouped according to glomerular filtration rate level (G1 to G5), proteinuria level (A1 to A3) and chronic kidney disease risk classification (low to very high). Kaplan-Meier and Cox proportional hazards analyses of overall survival were performed.
RESULTS: The preoperative glomerular filtration rate was less than 60 ml/minute/1.73 m(2) in 30% of patients (median 73, IQR 56-91) and 20% of patients had baseline proteinuria. According to the KDIGO (Kidney Disease Improving Global Outcomes) classification 23% of patients were at moderately increased, 11% were at high and 8% were at very high risk for chronic kidney disease progression. Kaplan-Meier analysis revealed that the preoperative glomerular filtration rate, proteinuria and chronic kidney disease risk group were associated with poor overall survival. In Cox proportional hazard models accounting for age, gender, race, tumor size, clinical stage and surgery type the glomerular filtration rate, proteinuria and chronic kidney disease risk group were highly significant predictors of overall survival (p <0.0001).
CONCLUSIONS: Preoperative proteinuria is a significant predictor of overall survival in patients who undergo nephrectomy. Classification according to preoperative glomerular filtration rate and proteinuria more accurately predicts survival than using the glomerular filtration rate alone after accounting for cancer stage. This information supports routine evaluation of proteinuria in patients with kidney cancer.
Copyright © 2016 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic; glomerular filtration rate; kidney failure; kidney neoplasms; mortality; proteinuria

Mesh:

Year:  2015        PMID: 26433140     DOI: 10.1016/j.juro.2015.09.083

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Trends in Percutaneous Thermal Ablation Therapies in the Treatment of T1a Renal Cell Carcinomas Rather than Partial Nephrectomy/Radical Nephrectomy.

Authors:  Sepideh Shakeri; Steven S Raman
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

2.  Impact of preoperative proteinuria on renal functional outcomes after open partial nephrectomy in patients with a solitary kidney.

Authors:  Hidekazu Tachibana; Tsunenori Kondo; Toshio Takagi; Masayoshi Okumi; Kazunari Tanabe
Journal:  Investig Clin Urol       Date:  2017-10-12

3.  Association Between Urinary Protein-to-Creatinine Ratio and Chronic Kidney Disease Progression: A Secondary Analysis of a Prospective Cohort Study.

Authors:  Xun Qin; Haofei Hu; Ji Cen; Xiaoyu Wang; Qijun Wan; Zhe Wei
Journal:  Front Med (Lausanne)       Date:  2022-03-31

4.  Comparison of Risk Factors for the Development of Proteinuria After Radical Nephrectomy for Renal Cell Carcinoma.

Authors:  Chung Un Lee; Don Kyoung Choi; Jae Hoon Chung; Wan Song; Minyong Kang; Hyun Hwan Sung; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee; Hwang Gyun Jeon
Journal:  Res Rep Urol       Date:  2021-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.